NEW YORK (TheStreet) -- CHANGE IN RATINGS
Advanced Micro Devices (AMD) was upgraded to hold at TheStreet Ratings.
On Assignment (ASGN) was upgraded at Wells Fargo to outperform from market perform. Estimates were also increased, given better core staffing trends, Wells Fargo said.
Bally (BYI) was downgraded at Goldman Sachs to sell from neutral. Twelve-month price target is now $62. Product momentum is slowing and the industry is facing headwinds, Goldman Sachs said.
Healthcare Realty Trust (HR) was upgraded to buy at TheStreet Ratings.
JB Hunt (JBHT - Get Report) was downgraded at Bank of America/Merrill Lynch. Twelve-month price target is $78. Burlington Northern service issues could constrain growth for a couple of quarters, BofA/Merrill said.
MSC Industrial Direct (MSM) was downgraded at UBS to neutral from buy. Valuation call, but long-term growth prospects driven by industry consolidation and improving industrial activity, UBS said. Twelve-month price target is $90.
NRG Energy (NRG) was upgraded at Goldman Sachs to buy from neutral. Company was also placed on the Conviction Buy list. Company can use considerable cash flow to buy back stock and debt, as well as to make acquisitions, Goldman said.
Must Read: Analysts' Actions: JNPR MFRM RBC SUSS WETF
Signature Bank (SBNY) was downgraded at Oppenheimer to perform from outperform. Valuation call, as the stock is up 20% year to date and trading with a price-to-earnings ratio of 21, based on expected full-year earnings, Oppenheimer said.
Under Armour (UA) was downgraded at Sterne Agee to neutral from buy. Valuation call, as the stock is up 42% year to date, Sterne Agee said. Three-year price target of $170.
Ulta Salon (ULTA) was upgraded at Goldman Sachs to buy from neutral. Twelve-month price target is $118. Company remains a compelling growth opportunity and can exceed consensus growth expectations, Goldman Sachs said.
ING (VOYA) was upgraded at Deutsche Bank to buy from hold. Twelve-month price target is $43. Company has several potential catalysts, Deutsche Bank said.
Wellcare (WCG) was upgraded at Leerink Swann to outperform from market perform. Twelve-month price target is now $74. Valuation call, as the company has multiple potential catalysts, Leerink Swann said.
Wex (WEX) was upgraded at Citigroup to buy from neutral. Twelve-month price target is $109. After recent meeting with CEO, have increased confidence in the company's accelerating growth profile, Citigroup said.